Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

1226–1250 of 11852

HighFDA (Drugs)·D-0247-2024·2024-01-24
Secret OUTLAST Dry Spray Antiperspirant recalled for potential benzene contamination
Procter & Gamble is recalling Secret OUTLAST Dry Spray Antiperspirant due to a manufacturing facility deviation where other lots were found contaminated with benzene. The recalled product was manufactured at the affected facility.
Product
Secret, OUTLAST, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Completely Clean, Topical spray can 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-384-10, UPC 0 37000 74764 2
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0237-2024·2024-01-24
Ibuprofen and Famotidine Tablets Recalled for Foreign Tablet Contamination
Ascend Laboratories is recalling 3,288 bottles of Ibuprofen and Famotidine tablets nationwide because a stray Rasagiline Mesylate tablet was discovered in an unopened bottle during quality control.
Product
IBUPROFEN AND FAMOTIDINE — IBUPROFEN AND FAMOTIDINE (IBUPROFEN AND FAMOTIDINE)
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0220-2024·2024-01-17
Prescription Vigabatrin Powder Recalled for Defective Container Leakage Risk
InvaGen Pharmaceuticals recalls Vigabatrin for Oral Solution nationwide due to defective containers that may leak. Consumers with affected lot should contact their pharmacy or healthcare provider.
Product
VIGABATRIN — VIGABATRIN (VIGABATRIN)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0219-2024·2024-01-17
Prescription Tacrolimus Capsules Recalled for Wrong-Strength Product Mix
Dr. Reddy's Laboratories is recalling 8,280 bottles of Tacrolimus 1 mg capsules after a 0.5 mg capsule was found in a bottle. The wrong-strength capsule could cause dosage confusion.
Product
TACROLIMUS — TACROLIMUS (TACROLIMUS)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0221-2024·2024-01-17
FDA Recalls Desloratadine Tablets Due to Manufacturing Defect
Lupin Pharmaceuticals is recalling Desloratadine 5mg tablets distributed nationwide because N-Nitroso impurity levels exceeded acceptable limits. Affected lots expire in January 2024.
Product
DESLORATADINE — DESLORATADINE (DESLORATADINE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0222-2024·2024-01-17
FDA recalls Bupropion Hydrochloride tablets for foreign tablet contamination
Rising Pharma Holdings is recalling 47,976 bottles of Bupropion Hydrochloride 150mg tablets nationwide due to foreign tablets or capsules found in some bottles. Consumers should stop use and contact their pharmacist immediately.
Product
BUPROPION HYDROCHLORIDE — BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0223-2024·2024-01-17
Tizanidine 4mg Tablets Recalled for Contamination with 2mg Tablets
Dr. Reddy's Laboratories is recalling Tizanidine 4mg tablets due to the presence of 2mg tablets in bottles. About 38,952 bottles were distributed nationwide.
Product
TIZANIDINE — TIZANIDINE (TIZANIDINE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0218-2024·2024-01-10
Peritoneal Dialysis Solution Recalled for Lack of Sterility Assurance
Fresenius Medical Care is recalling 69,590 bags of DELFLEX Peritoneal Dialysis Solution due to lack of sterility assurance. The affected lot was distributed nationwide.
Product
DELFLEX — DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0208-2024·2024-01-03
Sure Unscented Deodorant Aerosol Recalled for Benzene Contamination
Sure Unscented Deodorant Aerosol is being recalled nationwide due to benzene contamination. Consumers should stop using affected cans and contact the manufacturer.
Product
Sure Unscented Anti-perspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5517-06
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0206-2024·2024-01-03
Supplement Capsules Recalled for Undeclared Sildenafil Content Nationwide
Magnum XXL 9800 capsules contain undeclared sildenafil and were marketed without FDA approval. The product was distributed nationwide via Amazon.
Product
Magnum XXL 9800, 2000 mg per capsule, 1 capsule per blister pack, Distributed by Magnum Los Angelas CA. UPC 6 45759 99300 7. Amazon's ASIN# B07P7ZH797, B07P94J3ZT, B07P6VK6N3, B076HNPZZZ
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0207-2024·2024-01-03
Brut Classic Antiperspirant and Deodorant Recalled for Benzene Contamination
Brut Classic Antiperspirant & Deodorant in 4 oz and 6 oz aerosol cans is being recalled due to benzene contamination. The recall affects all lots distributed in the United States and Canada.
Product
Brut Classic Antiperspirant & Deodorant (aluminum chlorohydrate 20.9%) packaged in a) 4 oz. (113g) aerosol cans (UPC 00827755070085, NDC 41595-7103-1) and b) 6 oz. (170g) aerosol cans (UPC 00827755070108, NDC 41595-7103-2), Distributed by Idelle Labs, Ltd. El Paso, TX 79912 USA
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0209-2024·2024-01-03
Sure Regular Antiperspirant Deodorant Aerosol Recalled for Benzene Contamination
Sure Regular Antiperspirant Deodorant Aerosol (6 oz cans) sold nationwide in the US and Canada is being recalled due to benzene contamination. All lots expiring on or before August 2023 are affected.
Product
Sure Regular Antiperspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5518-06
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0201-2024·2024-01-03
Warfarin Sodium Tablets Recalled Due to Temperature Storage Deviation
Cardinal Healthcare recalls Warfarin Sodium Tablets (5 mg) nationwide due to CGMP deviations: products were exposed to temperatures outside labeled storage conditions, potentially affecting drug stability.
Product
WARFARIN SODIUM — WARFARIN SODIUM (WARFARIN SODIUM)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0161-2024·2024-01-03
Respiratory inhalation medication recalled for temperature storage deviation
Cardinal Healthcare is recalling an ipratropium bromide and albuterol sulfate inhalation solution nationwide after the product was exposed to temperatures outside labeled storage conditions. The deviation may affect drug potency.
Product
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0191-2024·2024-01-03
Metoprolol Succinate Extended-Release Tablets Recalled for Storage Temperature Deviations
Cardinal Healthcare is recalling Metoprolol Succinate Extended-Release Tablets (50 mg) nationwide. Batch 2447J211 was exposed to temperatures outside labeled storage conditions, which could compromise medication effectiveness.
Product
METOPROLOL SUCCINATE — METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0202-2024·2024-01-03
Prescription Inhalation Powder Recalled for Storage Temperature Deviation
Cardinal Healthcare recalls batch 62002532 of Wixela Inhub inhalation powder nationwide due to CGMP deviations. Products were exposed to temperatures outside labeled storage conditions, potentially affecting product stability.
Product
WIXELA INHUB — WIXELA INHUB (FLUTICASONE PROPIONATE AND SALMETEROL)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0196-2024·2024-01-03
Rivastigmine Transdermal Patch Recalled Due to Temperature Exposure
Cardinal Healthcare is recalling Rivastigmine Transdermal System patches (4.6 mg/24 hours) distributed nationwide because they were exposed to temperatures outside labeled storage conditions during manufacturing.
Product
RIVASTIGMINE TRANSDERMAL SYSTEM, Delivers 4.6 mg/24 hours, 30 systems per box, Rx Only, Distributed by: Alvogen, Inc., Morristown, NJ 07960. NDC 47781-304-03
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0200-2024·2024-01-03
Warfarin Sodium tablets recalled due to improper storage temperature exposure
Cardinal Healthcare recalls Warfarin Sodium tablets distributed nationwide due to products being exposed to improper storage temperatures.
Product
WARFARIN SODIUM — WARFARIN SODIUM (WARFARIN SODIUM)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0192-2024·2024-01-03
Topical antifungal Nyamyc recalled due to storage temperature deviations
Cardinal Healthcare is recalling Nyamyc topical antifungal medication (Batch 400454) nationwide due to exposure to temperatures outside labeled storage conditions.
Product
Nyamyc, 100,000 USP units per gram, 60 grams, Rx only, Topical Use Only, Manufactured by: Upsher-Smith Laboratories, Inc, Minneapolis, MN 55447.
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0177-2024·2024-01-03
Donepezil Hydrochloride Tablets Recalled Due to Storage Temperature Deviations
Cardinal Healthcare is recalling Donepezil Hydrochloride 5 mg tablets (Batch 17605) distributed nationwide because they were exposed to temperatures outside labeled storage conditions, which could affect drug stability.
Product
DONEPEZIL HYDROCHLORIDE — DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0189-2024·2024-01-03
Lithium Carbonate Extended-Release Tablets Recalled for Temperature Excursion
Cardinal Healthcare recalled Lithium Carbonate Extended-Release Tablets (300 mg, Batch 3138326) distributed nationwide because the products were exposed to temperatures outside their labeled storage conditions during manufacturing.
Product
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0171-2024·2024-01-03
Bumetanide Tablets Recalled for Exposure to Improper Storage Temperatures
Bumetanide tablets manufactured by Amneal Pharmaceuticals are being recalled because they were exposed to temperatures outside their labeled storage conditions. The recall affects batch AM211171 distributed nationwide.
Product
Bumetanide Tablets, USP, 2 mg, 100 Tablets per bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213 India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0163-2024·2024-01-03
Albuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
Cardinal Healthcare is recalling Albuterol Sulfate inhalers (Batch K100715) due to CGMP deviations where products were exposed to temperatures outside labeled storage conditions. Approximately 11 cartons were distributed nationwide. Contact your pharmacist or doctor for a replacement.
Product
ALBUTEROL SULFATE — ALBUTEROL SULFATE (ALBUTEROL SULFATE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0184-2024·2024-01-03
Drug Recall: Hydralazine Hydrochloride Tablets Due to Improper Storage
Cardinal Healthcare is recalling Hydralazine Hydrochloride tablets nationwide because products were exposed to temperatures outside labeled storage conditions due to manufacturing practice deviations.
Product
HYDRALAZINE HYDROCHLORIDE — HYDRALAZINE HYDROCHLORIDE (HYDRALAZINE HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0203-2024·2024-01-03
B-Complex Vitamin Injection Vials Recalled for Particulate Matter
AnazaoHealth is recalling B-Complex injection vials due to particulate matter contamination. Affected patients should discontinue use and consult their healthcare provider.
Product
B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

1226–1250 of 11852